High Growth Tech Stocks in Europe Featuring Pexip Holding and Two Others

The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index experiencing a decline amid geopolitical tensions and economic uncertainties, as seen in the downturns of major indexes like Germany’s DAX and France’s CAC 40. In this environment, identifying high-growth tech stocks such as Pexip Holding becomes crucial for investors seeking opportunities that can navigate these complexities by leveraging innovative technologies and robust business models to potentially outperform broader market trends.

Top 10 High Growth Tech Companies In Europe

Name Revenue Growth Earnings Growth Growth Rating Hacksaw 24.17% 25.33% ★★★★★★ 2CRSI 25.76% 65.41% ★★★★★★ Archos 31.61% 57.94% ★★★★★★ Pharma Mar 17.97% 31.32% ★★★★★☆ Yubico 10.99% 36.21% ★★★★★☆ Bonesupport Holding 23.74% 34.48% ★★★★★★ CD Projekt 32.85% 28.97% ★★★★★☆ KebNi 26.87% 82.69% ★★★★★★ SyntheticMR 18.81% 47.40% ★★★★★☆ Comet Holding 13.02% 57.14% ★★★★★☆

Click here to see the full list of 60 stocks from our European High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

Pexip Holding

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pexip Holding ASA is a video technology company that provides an end-to-end video conferencing platform and digital infrastructure across various global regions, with a market capitalization of NOK6.94 billion.

Operations: Pexip generates revenue primarily through the sale of collaboration services, amounting to NOK1.23 billion. The company operates in multiple regions, including the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Pexip Holding's recent financial performance underscores its robust position in the high-growth tech sector in Europe. With a notable 76.2% increase in earnings over the past year, Pexip has demonstrated a capacity to significantly outpace the software industry's growth rate of 11.1%. This is complemented by an impressive forecast of annual revenue and earnings growth at 9.7% and 21.5%, respectively, both figures surpassing Norwegian market averages. The company also recently announced a special dividend totaling NOK 4 per share, reflecting its strong financial health and commitment to shareholder returns. These factors collectively highlight Pexip's dynamic growth trajectory and solid market standing amidst evolving technological landscapes.

Dive into the specifics of Pexip Holding here with our thorough health report. Gain insights into Pexip Holding's past trends and performance with our Past report.OB:PEXIP Revenue and Expenses Breakdown as at Apr 2026

RaySearch Laboratories

Simply Wall St Growth Rating: ★★★★★☆

Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment globally, with a market cap of SEK7.56 billion.

Story Continues

Operations: The company generates revenue primarily from its healthcare software segment, totaling SEK1.34 billion.

RaySearch Laboratories, a leader in oncology software systems, is demonstrating significant growth and innovation. With annual revenue and earnings growth forecasted at 12.5% and 22.9% respectively, the company outpaces the Swedish market's average growth rates of 0.4% and 8.5%. Recent strategic moves include delivering RayStation treatment systems to Poltava Regional Cancer Clinic in Ukraine, enhancing cancer care capabilities during wartime, and expanding its footprint in China with integrated RayCare systems for advanced particle therapy at SPHIC. These initiatives not only underscore RaySearch's commitment to advancing global cancer treatment but also position it well for sustained future growth within the high-tech medical sector.

Delve into the full analysis health report here for a deeper understanding of RaySearch Laboratories. Learn about RaySearch Laboratories' historical performance.OM:RAY B Revenue and Expenses Breakdown as at Apr 2026

Truecaller

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Truecaller AB (publ) is a company that creates and distributes mobile caller ID applications for both individuals and businesses across India, the Middle East, Africa, and other international markets, with a market cap of approximately SEK3.94 billion.

Operations: Truecaller generates revenue primarily through its communications software segment, which reported SEK1.95 billion. The company focuses on developing and publishing mobile caller ID applications for a diverse range of international markets.

Truecaller, navigating the dynamic tech landscape in Europe, is enhancing its growth trajectory through strategic partnerships and a diversified revenue model. The company's shift to a multi-partner ecosystem for business messaging, moving away from exclusive agreements, marks a significant pivot designed to expand global reach and foster innovation. This transition is expected to temporarily impact revenues but promises robust long-term growth by broadening Truecaller’s client base and service capabilities. Additionally, recent share repurchases totaling SEK 197.06 million underscore confidence in the company’s future prospects amidst these transformative strategies.

Click to explore a detailed breakdown of our findings in Truecaller's health report. Assess Truecaller's past performance with our detailed historical performance reports.OM:TRUE B Revenue and Expenses Breakdown as at Apr 2026

Next Steps

Delve into our full catalog of 60 European High Growth Tech and AI Stocks here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Looking For Alternative Opportunities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OB:PEXIP OM:RAY B and OM:TRUE B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments